Dr. Iwanicki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
777 Bannock St
Denver, CO 80204Phone+1 303-436-7142
Education & Training
- Denver Health Medical CenterFellowship, Medical Toxicology (Emergency Medicine), 2012 - 2014
- Denver Health Medical CenterResidency, Emergency Medicine, 2008 - 2012
- University of California San Francisco School of MedicineClass of 2008
Certifications & Licensure
- CO State Medical License 2012 - 2025
- American Board of Emergency Medicine Emergency Medicine
- American Board of Emergency Medicine Medical Toxicology
Publications & Presentations
PubMed
- Buprenorphine, oxycodone, hydrocodone, and methadone mortality in the United States (2010‒2017).Karilynn M Rockhill, Gabrielle E Bau, Angela DeVeaugh-Geiss, Howard Chilcoat, Richard Dart
Journal of the American College of Emergency Physicians Open. 2024-10-01 - 1 citationsAbuse of tapentadol compared to other atypical opioids among individuals entering treatment for opioid use disorders.S Geoff Severtson, Marie C Gurrola, Mark W Parrino, Matthew S Ellis, Theodore J Cicero
Journal of Opioid Management. 2023-11-16 - Initiation Patterns and Transitions Among Adults Using Stimulant Drugs: Latent Transition Analysis.Joshua C Black, Hannah L Burkett, Karilynn M Rockhill, Richard Olson, Richard C Dart
Journal of Medical Internet Research. 2023-10-05
Journal Articles
- Association of Medical Stimulants with Mortality in the US from 2010 to 2017Janetta Iwanicki, MD, JAMA Internal Medicine
Press Mentions
- The AMA Does Not Speak for UsDecember 9th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: